Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Candida is a leading cause of healthcare-associated bloodstream infections in the United States. Infants and children have unique risk factors for candidemia, and the Candida species distribution in this group is different that among adults; however, candidemia epidemiology in this population has not been described recently. METHODS: We conducted active population-based candidemia surveillance in 4 US metropolitan areas between 2009 and 2015. We calculated incidences among neonates (0-30 days old), infants (0-364 days old), and noninfant children (1-19 years old), documented their clinical features and antifungal drug resistance. RESULTS: We identified 307 pediatric candidemia cases. Incidence trends varied according to site, but overall, the incidence in neonates decreased from 31.5 cases/100000 births in 2009 to 10.7 to 11.8 cases/100000 births between 2012 and 2015, the incidence in infants decreased from 52.1 cases/100000 in 2009 to 15.7 to 17.5 between 2012 and 2015, and the incidence in noninfant children decreased steadily from 1.8 cases/100000 in 2009 to 0.8 in 2014. Common underlying conditions were prematurity in neonates (78%), surgery in nonneonate infants (38%), and malignancy in noninfant children (28%). Most neonate cases were caused by C albicans (67%), whereas non-C. albicans species accounted for 60% of cases in nonneonate infants and noninfant children. Fluconazole and echinocandin resistance rates were low overall. Thirty-day crude mortality was 13%. CONCLUSIONS: The incidence of candidemia among neonates and infants declined after 2009 but remained stable from 2012 to 2015. Antifungal drug resistance is uncommon. Reasons for the lack of recent declines in neonatal and infant candidemia deserve further exploration. In this article, we describe the epidemiology of candidemia in children in the United States and on the basis of data collected as part of US Centers for Disease Control and Prevention active population-based surveillance. Trends in incidence, clinical characteristics, species distribution, and resistance rates are presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The incidence of candidemia started to decrease in the mid-1990s through the mid-2000s among low birthweight newborns, in part because of recommendations for fluconazole prophylaxis in certain settings (25–27).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [26]
In the citing paper
“This contrasts with data from the early 1990s, when infants had the highest incidence (6), followed by substantial decreases by the late 2000s (26,28).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [26]
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · cited 2×
“The 2009 and 2016 Infectious Diseases Society of America clinical practice guidelines for the management of candidiasis recommend antifungal prophylaxis in neonates who weigh less than 1000 g and are in a neonatal ICU (NICU) with a high candidemia rate [8, 9].”
BackgroundMultistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566
Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington-Skaggs, B., da Matta, D. A., Warnock, D., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 526
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523
Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Research works printed but not linked: 5
- CLSI document M27-A3, 2008, Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard–third edition
- M27-S4, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; 4th Informational Supplement
- National Center for Health Statistics, All-county birth data (2009–2015) as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program
- Blyth, 2009, Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients, Pediatrics, 123, 1360, 10.1542/peds.2008-2055 · DOI · Paper page
- Fanfair RN AA , FarleyM, et al Racial disparities in candidemia: results from population-based surveillance in the United States, 2008–2010. International Conference on Antimicrobials and Chemotherapeutics (ICAAC). Chicago, September 17–20, 2011.
Cited by
Lass-Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky- Zeichner, L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 298
“In addition, during the past few years, the population at risk expanded due to COVID-19-related C andida infections 164 and the emergence of fungal break-through infections 165 .”
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
Self-citationWarris, A., Pana, Z. D., Oletto, A., Lundin, R., Castagnola, E., Lehrnbecher, T., Groll, A. H., & Roilides, E. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002530 · Cited by 124
Recent Trends in the Epidemiology of Fungal Infections
Seagle, E. E., Williams, S., & Chiller, T. M. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.001 · Cited by 114
Self-citationParambath, S., Dao, A., Kim, H. Y., Zawahir, S., Alastruey‐Izquierdo, A., Tacconelli, E., Govender, N. P., Oladele, R. O., Colombo, A. L., Sorrell, T. C., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae045 · Cited by 110
“Benedict et al. 20 and Ryan et al. 54 also found that the overall incidence of candidaemia was decreasing over time in paediatric and adult populations.”
BackgroundCandida parapsilosis complex in the clinical setting
Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 94
“C. parapsilosis is among the most common Candida species involved in neonatal and paediatric candidiasis, with a proportion ranging from 14% to 75% in neonatal cases 76,77 and from 15% to 43% in children admitted to haematology, oncology or ICUs 78,79 .”
BackgroundInvasive fungal infections in neonates: a review
Weimer, K. E. D., Smith, P. B., Puia‐Dumitrescu, M., & Aleem, S. (2021) · Pediatric Research · doi:10.1038/s41390-021-01842-7 · Cited by 91
“parapsilosis (14–30%).(3,9,10) Other species, including C.”
Candidemia in children: Epidemiology, prevention and management
Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 77
Keighley, C., Cooley, L., Morris, A. J., Ritchie, D., Clark, J. E., Boan, P., & Worth, L. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15589 · Cited by 74
Neonatal invasive candidiasis: updates on clinical management and prevention
Kilpatrick, R., Scarrow, E. R., Hornik, C., & Greenberg, R. G. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00272-8 · Cited by 69
Berrío, I., Cáceres, D. H., Coronell-Rodríguez, W., Salcedo, S., Mora, L., Marín, A., Varón, C., Lockhart, S. R., Escandón, P., Berkow, E. L., et al. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa038 · Cited by 51
Self-citationMohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., & Al-Hatmi, A. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9100638 · Cited by 43
“Especially ICU patients with medical devices such as central venous catheters (CVC) or urinary catheters, treatment with broad-spectrum antibiotics, long hospital stays, major surgery and immunosuppressive therapy are affected [1,12,13].”
BackgroundEpidemiology of Culture-confirmed Candidemia Among Hospitalized Children in South Africa, 2012–2017
Shuping, L., Mpembe, R. S., Mhlanga, M., Naicker, S. D., Maphanga, T. G., Tsotetsi, E., Wadula, J., Velaphi, S., Nakwa, F. L., Chibabhai, V., et al. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003151 · Cited by 47
Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort
Lausch, K. R., Dungu, K. H. S., Callesen, M. T., Schrøder, H. D., Rosthøj, S., Poulsen, A., Østergaard, L. J., Mortensen, K. L., Storgaard, M., Schønheyder, H. C., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002207 · Cited by 47
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Jillwin, J., Iyer, R. N., Sharma, A., Harish, B. N., Roy, I., Kindo, A. J., et al. (2020) · Mycoses · doi:10.1111/myc.13145 · Cited by 44
Dawoud, A. M., Saied, S. A., Torayah, M. M., Ramadan, A. E., & Elaskary, S. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-61813-w · Cited by 44
“Yardimci et al. 24 reported that micafungin sensitivity was the highest (97.4”
BackgroundInfluentialDermitzaki, N., Baltogianni, M. S., Tsekoura, E., & Giapros, V. I. (2024) · Pathogens · doi:10.3390/pathogens13080660 · Cited by 38
Gan, M. Y., Lee, W. L., Yap, B. J., Seethor, S. T. T., Greenberg, R. G., Pek, J. H., Tan, B., Hornik, C. P. V., Lee, J. H., & Chong, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.890767 · Cited by 39
Invasive Candida Infections in Neonates after Major Surgery: Current Evidence and New Directions
Rose, D. U. D., Santisi, A., Ronchetti, M. P., Martini, L., Serafini, L., Betta, P., Maino, M., Cavigioli, F., Cocchi, I., Pugni, L., et al. (2021) · Pathogens · doi:10.3390/pathogens10030319 · Cited by 39
Reda, N. M., Hassan, R. M., Salem, S. T., & Yousef, R. (2022) · Infection · doi:10.1007/s15010-022-01888-7 · Cited by 40
“In contrast to our study, C parapsilosis was reported as the most notable NAC species among infants and children in several studies and this has been attributed to its association with catheters, which results from its capability to stick on plastic and the power to thrive in parenteral nutrition [23, 37].”
BackgroundResultCáceres, D. H., Rivera, S. M., Armstrong, P. A., Escandón, P., Chow, N. A., Ovalle, M. V., Díaz, J., Derado, G., Salcedo, S., Berrío, I., et al. (2020) · Mycopathologia · doi:10.1007/s11046-020-00478-1 · Cited by 32
Self-citationChen, Y.-N., Hsu, J., Chu, S., Lai, M., Lin, C., Huang, H., Yang, P., Chiang, M., & Tsai, M.-H. (2022) · Journal of Fungi · doi:10.3390/jof8050465 · Cited by 32
Yeoh, D. K., Moore, A. S., Kotecha, R. S., Bartlett, A. W., Ryan, A. L., Cann, M. P., McMullan, B. J., Thursky, K., Slavin, M. A., Blyth, C. C., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29275 · Cited by 30
Clinical practice update of antifungal prophylaxis in immunocompromised children.
Ramos, J. T., Romero, C. A., Belda, S., Candel, F. J., Gallego, B. C., Fernández-Polo, A., Ferreras-Antolin, L., Colino, C. G., Navarro, M. L. M., Nef, O., et al. (2019) · PubMed Central · Cited by 38
Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period
Noni, M., Stathi, A., Vaki, I., Velegraki, A., Zachariadou, L., & Michos, A. G. (2019) · Journal of Fungi · doi:10.3390/jof5010019 · Cited by 28
Health care-associated invasive Candida infections in children
Öncü, B., Belet, N., Emecen, A. N., & Bırıncı, A. (2019) · Medical Mycology · doi:10.1093/mmy/myz005 · Cited by 24
Candida glabrata: A Tale of Stealth and Endurance
Askari, F., & Kaur, R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00477 · Cited by 24
Advances in the Treatment of Mycoses in Pediatric Patients
Iosifidis, Ε., Papachristou, S., & Roilides, E. (2018) · Journal of Fungi · doi:10.3390/jof4040115 · Cited by 20
Neonatal Invasive Candidiasis: Current Concepts
Ferreras-Antolin, L., Chowdhary, A., & Warris, A. (2025) · The Indian Journal of Pediatrics · doi:10.1007/s12098-025-05593-9 · Cited by 19
Rossow, J. A., Gharpure, R., Brennan, J., Relan, P., Williams, S. R., Vallabhaneni, S., Jackson, B. R., Graber, C. R., Hillis, S. R., Schaffner, W., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa024 · Cited by 17
“7/100 000), incidence among PWID was at least 7 times higher [24, 25].”
BackgroundSelf-citationChen, X., Shen, M., Feng, Q., Yang, G., Tian, R., Yao, S., & Zha, H. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11021-2 · Cited by 17
“C. parapsilosis was the leading non-C. albicans species in candidemia is consistent with reports from tertiary hospitals in Beijing and Guangzhou, China [25, 38], and its propensity to infect pediatric populations [41, 42].”
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates
Baltogianni, M. S., Giapros, V. I., & Dermitzaki, N. (2024) · Children · doi:10.3390/children11101207 · Cited by 20
“[8,11,15–17].”
Yeoh, D. K., Haeusler, G. M., McMullan, B. J., Butters, C. T., Bryant, P. A., Clark, J. E., Cooper, C. M., Gwee, A., Kotecha, R. S., Lai, T., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac060 · Cited by 16
Aziz, H. S. A., Ismail, D. K., Mohammed, N. N., Elgendy, M. O., & Bassiouny, D. M. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10007-w · Cited by 17
Risk factors and outcomes of deep tissue Candida invasion in neonates with invasive candidiasis
Eisi, H., Ibraheem, S., Hisham, T., Al‐Harbi, A., Saidy, K., Ali, I. M., Nour, I., & Nasef, N. (2021) · Mycoses · doi:10.1111/myc.13395 · Cited by 15
Auriti, C., Rose, D. U. D., Santisi, A., Martini, L., Ronchetti, M. P., Ravà, L., Antenucci, V., Bernaschi, P., Serafini, L., Catarzi, S., et al. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.09.018 · Cited by 15
Al-Otaibi, H., Asadzadeh, M., Ahmad, S., Al‐Sweih, N., & Joseph, L. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101123 · Cited by 14
Yang, Q., He, B., Chen, C., Wang, H., Li, W., Xue, X., Qiu, T., Hao, X., Lv, F., & Wang, S. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00393 · Cited by 15
The phosphatome of opportunistic pathogen Candida species
Szabó, K., Miskei, M., Farkas, I., & Dombrádi, V. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2020.12.002 · Cited by 18
Zeng, Z., Tian, G., Ding, Y., Yang, K., Deng, J. M., & Liu, J. (2020) · Mycoses · doi:10.1111/myc.13146 · Cited by 13
Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study
Kaur, H., Singh, S., Rudramurthy, S. M., Jayashree, M., Peters, N. J., Ray, P., Samujh, R., Ghosh, A. K., & Chakrabarti, A. (2021) · Mycoses · doi:10.1111/myc.13297 · Cited by 13
Fatal Lodderomyces elongisporus Fungemia in a Premature, Extremely Low-Birth-Weight Neonate
Asadzadeh, M., Al‐Sweih, N., Ahmad, S., Khan, S. I., Alfouzan, W. A., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8090906 · Cited by 14
Evaluation of candidemia in children at a university hospital: A retrospective cohort
Özenen, G. G., Bal, Z. Ş., Avcu, G., Yazıcı, P., Karakoyun, M., Metin, D. Y., & Polat, S. H. (2023) · Mycoses · doi:10.1111/myc.13564 · Cited by 10
Updates in Laboratory Identification of Invasive Fungal Infection in Neonates
He, B., & Yang, Q. (2023) · Microorganisms · doi:10.3390/microorganisms11041001 · Cited by 10
Sokou, R., Palioura, A. E., Konstantinidi, A., Lianou, A., Lampridou, M., Theodoraki, M., Piovani, D., Bonovas, S., Tsante, K. A., Ιωάννου, Π., et al. (2024) · Journal of Fungi · doi:10.3390/jof11010017 · Cited by 7
Recent changes in candidemia trends in a tertiary hospital (2011–2018)
Piqueras, A. I., Rubio, T. T., Medina, E. M. L., Gimeno, A., Modesto, V., Cantón, E., & Pemán, J. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.005 · Cited by 7
Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence Study
Chorafa, E., Iosifidis, Ε., Oletto, A., Warris, A., Castagnola, E., Brüggemann, R. J. M., Groll, A. H., Lehrnbecher, T., Ferreras-Antolin, L., Mesini, A., et al. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004445 · Cited by 6
Murphy, C. R., Teoh, Z., Whitehurst, D. A., Brammer, C. N., Perkins, K., Paulsen, G. C., Miller‐Handley, H., Danziger‐Isakov, L. A., & Otto, W. R. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004212 · Cited by 6
“The epidemiology of metastatic complications in neonates is poorly described, 10,24,25 but Festekjian et al 16 did identify prematurity as a risk factor for dissemination in univariate analyses.”
BackgroundPerspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit
Dermitzaki, N., Balomenou, F., Gialamprinou, D., Giapros, V. I., Rallis, D., & Baltogianni, M. S. (2024) · Antibiotics · doi:10.3390/antibiotics13121209 · Cited by 7
Invasive Fungal Infections in the Neonatal Intensive Care Unit
Terzić, S., & Zgalj, A. (2025) · Cureus · doi:10.7759/cureus.79620 · Cited by 5
“Several studies agree with our results that C. albicans is still the dominant cause of IFIs [9,13-15].”
InfluentialAnálise epidemiológica da candidemia e espécies fúngicas envolvidas
de Sousa, L. X., Sousa, L. C. O., Cruz, J. H. D. A., de Queiroz, R. G., Ribeiro, E. D., & Freire, J. C. P. (2020) · ARCHIVES OF HEALTH INVESTIGATION · doi:10.21270/archi.v9i6.4830 · Cited by 5
Comparisons of the clinical and mycological characteristics of pediatric candidemia
Chen, W.-C., Chen, P., Yang, S.-C., Yen, T., Lu, C., Chen, J., Lee, P., Chang, L., Chen, Y., & Huang, L. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.11.009 · Cited by 5
Korem, M., Taragin, A., Dror, D., Temper, V., & Averbuch, D. (2023) · Journal of Fungi · doi:10.3390/jof9121171 · Cited by 5
“This finding is perhaps related to the relatively high proportion of immunocompromised patients with candidemia episodes (52%, Table 1), compared with 15.3–35.0% of such patients in other studies with lower mortality rates [2,23].”
BackgroundResultInfluentialEpidemiology of Candidemia in Children and Neonates in Korea, 2009–2018: A Multi-Center Study
Choi, J., Choi, S. R., Choi, S., Ahn, J. G., Kang, J., Heo, S., Yoon, Y., Kim, Y. K., Cho, H., & Kim, Y. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e201 · Cited by 4
“6,10-15,27,28 Neonates tend to show higher mortality than other age groups in most studies.”
Addressing the silent threat: managing invasive Candida infections in hospitalized newborns
Zhang, D., Xie, D., Yuan, H., He, N., Dong, W., & Lei, X. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1613832 · Cited by 6
“A series of multicenter epidemiological studies present a high prevalence of Candida albicans in Northern Europe (37), the United States (38), England (39), Canada (40), and Saudi Arabiaand (41), accounting for more than 50% of Candida isolates.”
InfluentialRisk factors and mortality of candidemia in a children's public hospital in Sao Paulo, Brazil
Sieben, R. G., la Ossa, R. P.-D., Waack, A., Aragon, D. C., Bellissimo‐Rodrigues, F., do Prado, S. I., & Cervi, M. C. (2024) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2023.09.002 · Cited by 4
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects
Eletel, L., Thomas, T., Berry, E. A., & Kearns, G. L. (2025) · Pediatric Drugs · doi:10.1007/s40272-025-00688-4 · Cited by 4
Candida lusitaniae Fungemia in Children: A multicenter case series of emerging pathogen
Snapiri, O., Danziger, C. R., Sachs, N., Krause, I., Zvi, H. B., Danino, D., Kriger, O., Shachor‐Meyouhas, Y., Averbuch, D., & Bilavsky, E. (2024) · Medical Mycology · doi:10.1093/mmy/myae057 · Cited by 4
Antifungal Prescription and Stewardship in Pediatrics
Evangelidis, P., Chorafa, E., Kourti, M., Pilianidis, E., & Iosifidis, Ε. (2025) · Mycopathologia · doi:10.1007/s11046-025-01011-y · Cited by 3
Diagnosis and Management of Candidemia and Invasive Candidiasis in Neonates and Children
Warris, A., & Ferreras-Antolin, L. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005082 · Cited by 3
Yazdanpanah, S., Shafiekhani, M., Zare, Z., Nikoupour, H., Geramizadeh, B., Chamanpara, P., Jabrodini, A., Ahmadi, M., Malekizadeh, Z., Anbardar, M. H., et al. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101522 · Cited by 2
Case report: a case of neonatal Candida osteomyelitis with septic arthritis and literature review
Zhao, Y., Dai, L., Wang, L., & Wang, L. (2026) · BMC Pediatrics · doi:10.1186/s12887-025-06358-1 · Cited by 2
“Resistance to first-line antifungal treatment in infants is rare [39], but lipid formulations of amphotericin B are not routinely recommended for neonates [1].”
Mayasari, E., & Siregar, C. (2026) · International Journal of Microbiology · doi:10.1155/ijm/1517489 · Cited by 2
da Silva, C. M., de Lima-Neto, R. G., de Carvalho, A. M. R., Macêdo, D. P. C., Melo, A. S. D. A., & Neves, R. P. (2024) · Letters in Applied Microbiology · doi:10.1093/lambio/ovae044 · Cited by 2
Candidíase e candidemia neonatal: Revisão de literatura
Luz, G. A., Schneider, G. C., & do Carmo, M. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14326 · Cited by 4
Clinicopathologic Characterization of Invasive Fungal Intestinal Infections in Pediatric Patients
Shaheen, M., Lei, G.-S., Relich, R. F., & González, I. (2024) · Pediatric and Developmental Pathology · doi:10.1177/10935266241272564 · Cited by 1
Peripheral venous catheter–related candidemia in an immunocompetent child
Sudo, Y., Kawamura, Y., Miura, H., Yokoi, K., & Yoshikawa, T. (2021) · Pediatrics International · doi:10.1111/ped.14883 · Cited by 1
Otto, W. R., Steinbach, W. J., & Fisher, B. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00243-3 · Cited by 1
Candidaemia in Neonatal Intensive Care Units (NICU) at Beni-Suef Governorate
Radi, N., Mabrook, A., Tohamy, M., & Abdel-Aziz, M. (2023) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2023.293577 · Cited by 1
Analysis of a fluency method and a phonics method of reading instruction in third-grade students
Czepull, T. K. (2007) · Cited by 1
Doorley, L. A. (2023) · doi:10.21007/etd.cghs.2023.0620 · Cited by 1
Guerguis, S., Lee, P., & Goldman, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21024-8
Candidemia in Non-neutropenic Pediatric Patients in an Intensive Care Unit
Demir, S. Ö., Bacalan, F., Çevik, S., PİRİNÇÇİOĞLU, H. Ç., Kılınç, M. A., & TOMAR, L. (2021) · Journal of Contemporary Medicine · doi:10.16899/jcm.843796 · Cited by 1
Huang, F.-J., Xiong, T., & Tang, J. (2022) · PubMed · doi:10.7499/j.issn.1008-8830.2204158
Naderalvojood, F., Sadeghi, E., Noroozi, M., & Nasimfar, A. (2025) · Afghanistan Journal of Infectious Diseases · doi:10.60141/ajid.77
“Candidemia (blood’s infection with various Candida species) is one of the five common hospitals’ infections amongst the risk factors of which malignancy, prematurity and surgery during postnatal period can be pointed out (16,17).”
Greenberg, R. G., Fisher, B. T., & Otto, W. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00217-x
Nhiễm nấm máu ở trẻ đẻ non dưới 32 tuần: Đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị
Nga, N. T. Q., Công, B. T., Thủy, Đ. T. T., Nguyên, P. T., & Quang, L. Đ. (2025) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v193i8.3376
Investigation of a Fungus Specific Protein Phosphatase
Szabó, K. T. (2020) · University of Debrecen Electronic Archive (University of Debrecen)
Jirón Ayerdis, A. Y. (2020) · Repositorio Universidad Nacional Autonoma de Nicaragua-Managua (Universidad Nacional Autonoma de Nicaragua Managua)
Irrational and Inappropriate Use of Antifungals in the NICU: A Narrative Review
Dermitzaki, N., Balomenou, F., Kosmeri, C., Baltogianni, M. S., Nikolaou, A. I., Serbis, A., & Giapros, V. I. (2026) · Antibiotics · doi:10.3390/antibiotics15010073
Neonatal Candidemia in Latin America: Trends, Resistance, and Prevention Strategies (2008–2025)
Guzmán, F. G. S., Rivas-Pinedo, P., & Oñate-Gutiérrez, J. M. (2026) · Journal of Fungi · doi:10.3390/jof12030230
“A notable epidemiological finding was geographical variability: C. albicans predominated in northern and western European countries, while a higher proportion of C. parapsilosis sensu lato (s.I.) was observed in southern countries [7,8].”
InfluentialOdoom, A., Osman, A.-H., Ntim, O. K., Kotey, F. C. N., & Donkor, E. S. (2026) · Health Science Reports · doi:10.1002/hsr2.72738
“Recent reports have shown a decrease in the prevalence of candidemia in developed countries, but the same cannot be said in developing countries due to the unavailability of effective surveillance data and large, multicentre studies [31, 32].”
Alby‐Laurent, F., Obadia, T., Gits‐Muselli, M., Bougnoux, M., Brethon, B., Mariani‐Kurkdjian, P., Guitard, J., Botterel, F., Chachaty, É., Sitbon, K., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104177
“5 16 Due to potential differences between adult and paediactric populations in terms of ecology, pathophysiology, underlying conditions and mortality of bloodstream yeast infections, additional pediatric data is crucial to better identify children at risk of yeast fungemia and improve case…”
Nasrallah, E. T., Magid, A., Stein, M., Gelman, E., Danino, D., Hadad, L., Ashkenazi‐Hoffnung, L., Mor, M., Sachs, N., Shechter, N., et al. (2026) · Journal of Fungi · doi:10.3390/jof12090695
“Overall, fluconazole resistance was recorded in 12.7% of isolates, predominantly among C. parapsilosis and C. glabrata , which is consistent with rates reported in previous studies [2,17].”
InfluentialAntifungal therapy for newborn infants with invasive fungal infection
Prasad, R., Sk, M. H., Saha, B., Sahoo, J., Kumar, A., Fiander, M., Cracknell, J., McGuire, W., & supported by the Cochrane Neonatal Review Group (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003953.pub4
Metadata
- Authors
- Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., Hollick, R., Beldavs, Z. G., Zhang, A. Y., Schaffner, W., Graber, C. R., Derado, G., Chiller, T. M., Lockhart, S. R., & Vallabhaneni, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Johns Hopkins University (US)
- Maryland Emerging Infections Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- Acute and Communicable Disease Prevention, Oregon Health Authority, Portland
- Oregon Health Authority (US)
- Vanderbilt University (US)
- Corresponding author
- Vallabhaneni, Snigdha
- ORCID
- Venue
- Journal of the Pediatric Infectious Diseases Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-07
- Volume
- 7
- Issue
- 3
- Pages
- e78-e85
- ISSN
- 2048-7193 (ISSN-L)
- 2048-7207
- OpenAlex
- W2789278748
- Cited by
- 81
- References
- 49
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 15 · 2023: 7 · 2022: 8 · 2021: 16 · 2020: 9 · 2019: 5 · 2018: 3
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the Pediatric Infectious Diseases Society (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, neonatal candidemia, Candida albicans, non-albicans Candida, antifungal resistance, fluconazole resistance, echinocandin resistance, healthcare-associated bloodstream infections, preterm birth, mortality, risk factors, United States metropolitan areas, 2009 H1N1 influenza
- MeSH terms
- Adolescent, Antifungal Agents, Candida albicans, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Male, Population Surveillance, Prospective Studies, Risk Factors, United States, Fluconazole, Incidence, Drug Resistance, Fungal, Echinocandins, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.